Stay updated on Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now displays 'No longer looking for participants' and introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment label is standardized, and a Revision: v3.6.0 tag is added while the previous Intervention / Treatment heading is removed.
    Difference
    0.3%
    Check dated 2026-06-15T08:35:26.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5, indicating a new version of the page. No specific content changes are described in the provided diff.
    Difference
    0.0%
    Check dated 2026-06-08T04:23:29.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added, replacing the previous v3.5.3. This indicates a minor, behind-the-scenes update to the page's template and system.
    Difference
    0.0%
    Check dated 2026-05-17T10:02:47.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    This update reflects a minor site/version revision change, updating the displayed ClinicalTrials.gov release version from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-25T18:39:41.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:32:34.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added 'Thyroid gland undifferentiated (anaplastic) carcinoma' as a terminology/MeSH term in the study record. This update appears to be a metadata/terminology addition rather than a change to core study content.
    Difference
    0.0%
    Check dated 2026-03-28T03:04:48.000Z thumbnail image

Stay in the know with updates to Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page.